![Jeong-Woo Jo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeong-Woo Jo
Direktör/Styrelseledamot på
Arvelle Therapeutics International GmbH
Profil
Jeong-Woo Cho is currently the Director at Arvelle Therapeutics International GmbH since 2019 and the President-Future Growth at SK Life Science, Inc. since 2017.
Previously, he served as the President-Future Growth at SK Biopharmaceuticals Co., Ltd. from 2017 to 2023.
Aktiva positioner av Jeong-Woo Jo
| Företag | Position | Start |
|---|---|---|
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Direktör/Styrelseledamot | 2019-01-01 |
SK Life Science, Inc.
 SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Företagsledare/Principal | 2023-01-01 |
Tidigare kända positioner av Jeong-Woo Jo
| Företag | Position | Slut |
|---|---|---|
| SK BIOPHARMACEUTICALS CO., LTD. | Verkställande Direktör | 2023-01-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
21
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
SK Biopharmaceuticals Co., Ltd.
 SK Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of new drugs and antibiotics | Health Technology |
SK Life Science, Inc.
SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Commercial Services |
Arvelle Therapeutics International GmbH
Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Develops and commercializes therapeutic for patients suffering from CNC disorders | Health Technology |
